l.trevino
TL2 Moderator · Genoa
Contributes reviews on supplier material. Based in Genoa.
Joined 3 January 2025 · last posted 3d
66Posts here
1Topics
0Solutions
1.5kLikes received
1.8kLikes given
25Badges
220Days visited
4.5kPosts read
Recent activity
Full stream-
Documenting a supplier's response to a discrepancy Replied, post #48 · Sourcing › Vendor reports · 25 Jul 2026 · 32 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #118 · Evidence › Journal club · 19 Jul 2026 · 0 likes This follows post #115 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Programming during a large energy deficit Replied, post #38 · Nutrition & Training › Resistance training · 12 Jul 2026 · 15 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Revisiting: The best-written scientific paper you have read Replied, post #86 · Lounge › Off topic · 12 Jul 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
How shortages have affected compounding permissions Replied, post #30 · Access › Shortages · 11 Jul 2026 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #7 · Clinical › Prescriber conversations · 4 Jul 2026 · 2 likes I read post #5 twice before replying, because I had assumed the opposite. Discussing off-label dosing: if you want to dose differently than the label specifies (slower…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #78 · Evidence › Journal club · 3 Jul 2026 · 11 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 6 likes Worth separating two things that post #6 runs together. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea,…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #44 · Access › International · 29 Jun 2026 · 6 likes post #43 answers the question as asked. The question underneath it is different. Currency and exchange rates: paying in different currencies has different costs and…
-
Reading a home test result without over-claiming Replied, post #88 · Analytics › Home & field testing · 21 Jun 2026 · 10 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #92 · Practice › Reconstitution · 21 Jun 2026 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #51 · Analytics › Home & field testing · 16 Jun 2026 · 27 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…